Protocol Ledger

NCT03606408 · Phase II · COMPLETED

Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699

Interventional Phase II clinical trial protocol NCT03606408 sponsored by RECORDATI GROUP in Endocrinology, Obesity, and Metabolic, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-10-05 Enrollment: 127 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03606408
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)127 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03606408
Protocol FieldVerified Registry Value
NCT IdentifierNCT03606408
Consolidated Lead SponsorRECORDATI GROUP
Therapeutic Condition CohortEndocrinology, Obesity, and Metabolic
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment127 participants (ACTUAL)
Registered Start Date2018-10-05
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI